---
keywords:
  - Computer Vision
  - Parkinson's Disease Diagnosis
  - Supervised Learning
  - Medical Imaging
category: cs.AI
publish_date: 2025-09-23
arxiv_id: 2509.17566
---

<!-- KEYWORD_LINKING_METADATA:
{
  "processed_timestamp": "2025-09-24T00:01:55.483667",
  "vocabulary_version": "1.0",
  "selected_keywords": [
    "Computer Vision",
    "Parkinson's Disease Diagnosis",
    "Supervised Learning",
    "Medical Imaging"
  ],
  "rejected_keywords": [],
  "similarity_scores": {
    "Computer Vision": 0.78,
    "Parkinson's Disease Diagnosis": 0.79,
    "Supervised Learning": 0.81,
    "Medical Imaging": 0.77
  },
  "extraction_method": "AI_prompt_based",
  "budget_applied": true,
  "candidates_json": {
    "candidates": [
      {
        "surface": "2D Vision Foundation Models",
        "canonical": "Computer Vision",
        "aliases": [
          "2D VFMs",
          "Vision Foundation Models"
        ],
        "category": "broad_technical",
        "rationale": "Connects to the broader field of computer vision, which is crucial for understanding the adaptation of 2D models to 3D medical imaging.",
        "novelty_score": 0.45,
        "connectivity_score": 0.88,
        "specificity_score": 0.65,
        "link_intent_score": 0.78
      },
      {
        "surface": "Parkinson's Disease Diagnosis",
        "canonical": "Parkinson's Disease Diagnosis",
        "aliases": [
          "PD Diagnosis"
        ],
        "category": "unique_technical",
        "rationale": "Represents a specific application area for medical imaging and machine learning, facilitating links to related healthcare studies.",
        "novelty_score": 0.72,
        "connectivity_score": 0.67,
        "specificity_score": 0.85,
        "link_intent_score": 0.79
      },
      {
        "surface": "Multi-ROI Supervised Contrastive Learning",
        "canonical": "Supervised Learning",
        "aliases": [
          "Multi-ROI Contrastive Learning"
        ],
        "category": "specific_connectable",
        "rationale": "Highlights a specific learning technique that enhances model performance, linking to broader machine learning discussions.",
        "novelty_score": 0.68,
        "connectivity_score": 0.75,
        "specificity_score": 0.82,
        "link_intent_score": 0.81
      },
      {
        "surface": "QSM and NM-MRI Images",
        "canonical": "Medical Imaging",
        "aliases": [
          "QSM",
          "NM-MRI"
        ],
        "category": "broad_technical",
        "rationale": "Essential for linking discussions on specific imaging modalities used in medical diagnostics.",
        "novelty_score": 0.5,
        "connectivity_score": 0.83,
        "specificity_score": 0.7,
        "link_intent_score": 0.77
      }
    ],
    "ban_list_suggestions": [
      "automatic diagnosis",
      "dataset",
      "accuracy"
    ]
  },
  "decisions": [
    {
      "candidate_surface": "2D Vision Foundation Models",
      "resolved_canonical": "Computer Vision",
      "decision": "linked",
      "scores": {
        "novelty": 0.45,
        "connectivity": 0.88,
        "specificity": 0.65,
        "link_intent": 0.78
      }
    },
    {
      "candidate_surface": "Parkinson's Disease Diagnosis",
      "resolved_canonical": "Parkinson's Disease Diagnosis",
      "decision": "linked",
      "scores": {
        "novelty": 0.72,
        "connectivity": 0.67,
        "specificity": 0.85,
        "link_intent": 0.79
      }
    },
    {
      "candidate_surface": "Multi-ROI Supervised Contrastive Learning",
      "resolved_canonical": "Supervised Learning",
      "decision": "linked",
      "scores": {
        "novelty": 0.68,
        "connectivity": 0.75,
        "specificity": 0.82,
        "link_intent": 0.81
      }
    },
    {
      "candidate_surface": "QSM and NM-MRI Images",
      "resolved_canonical": "Medical Imaging",
      "decision": "linked",
      "scores": {
        "novelty": 0.5,
        "connectivity": 0.83,
        "specificity": 0.7,
        "link_intent": 0.77
      }
    }
  ]
}
-->

# MRN: Harnessing 2D Vision Foundation Models for Diagnosing Parkinson's Disease with Limited 3D MR Data

## ğŸ“‹ ë©”íƒ€ë°ì´í„°

**Links**: [[daily_digest_20250923|20250923]] [[categories/cs.AI|cs.AI]]
**PDF**: [Download](https://arxiv.org/pdf/2509.17566.pdf)
**Category**: cs.AI
**Published**: 2025-09-23
**ArXiv ID**: [2509.17566](https://arxiv.org/abs/2509.17566)

## ğŸ”— ìœ ì‚¬í•œ ë…¼ë¬¸
- [[2025-09-19/Ensemble of Pathology Foundation Models for MIDOG 2025 Track 2_ Atypical Mitosis Classification_20250919|Ensemble of Pathology Foundation Models for MIDOG 2025 Track 2: Atypical Mitosis Classification]] (84.3% similar)
- [[2025-09-22/NeuroRAD-FM_ A Foundation Model for Neuro-Oncology with Distributionally Robust Training_20250922|NeuroRAD-FM: A Foundation Model for Neuro-Oncology with Distributionally Robust Training]] (83.8% similar)
- [[2025-09-18/Non-Intrusive Parametrized-Background Data-Weak Reconstruction of Cardiac Displacement Fields from Sparse MRI-like Observations_20250918|Non-Intrusive Parametrized-Background Data-Weak Reconstruction of Cardiac Displacement Fields from Sparse MRI-like Observations]] (83.5% similar)
- [[2025-09-22/Self-supervised learning of imaging and clinical signatures using a multimodal joint-embedding predictive architecture_20250922|Self-supervised learning of imaging and clinical signatures using a multimodal joint-embedding predictive architecture]] (83.2% similar)
- [[2025-09-22/iCBIR-Sli_ Interpretable Content-Based Image Retrieval with 2D Slice Embeddings_20250922|iCBIR-Sli: Interpretable Content-Based Image Retrieval with 2D Slice Embeddings]] (83.2% similar)

## ğŸ·ï¸ ì¹´í…Œê³ ë¦¬í™”ëœ í‚¤ì›Œë“œ
**ğŸ§  Broad Technical**: [[keywords/Computer Vision|Computer Vision]], [[keywords/Medical Imaging|Medical Imaging]]
**ğŸ”— Specific Connectable**: [[keywords/Supervised Learning|Supervised Learning]]
**âš¡ Unique Technical**: [[keywords/Parkinson's Disease Diagnosis|Parkinson's Disease Diagnosis]]

## ğŸ“‹ ì €ì ì •ë³´

**Authors:** 

## ğŸ“„ Abstract (ì›ë¬¸)

arXiv:2509.17566v1 Announce Type: cross 
Abstract: The automatic diagnosis of Parkinson's disease is in high clinical demand due to its prevalence and the importance of targeted treatment. Current clinical practice often relies on diagnostic biomarkers in QSM and NM-MRI images. However, the lack of large, high-quality datasets makes training diagnostic models from scratch prone to overfitting. Adapting pre-trained 3D medical models is also challenging, as the diversity of medical imaging leads to mismatches in voxel spacing and modality between pre-training and fine-tuning data. In this paper, we address these challenges by leveraging 2D vision foundation models (VFMs). Specifically, we crop multiple key ROIs from NM and QSM images, process each ROI through separate branches to compress the ROI into a token, and then combine these tokens into a unified patient representation for classification. Within each branch, we use 2D VFMs to encode axial slices of the 3D ROI volume and fuse them into the ROI token, guided by an auxiliary segmentation head that steers the feature extraction toward specific brain nuclei. Additionally, we introduce multi-ROI supervised contrastive learning, which improves diagnostic performance by pulling together representations of patients from the same class while pushing away those from different classes. Our approach achieved first place in the MICCAI 2025 PDCADxFoundation challenge, with an accuracy of 86.0% trained on a dataset of only 300 labeled QSM and NM-MRI scans, outperforming the second-place method by 5.5%.These results highlight the potential of 2D VFMs for clinical analysis of 3D MR images.

## ğŸ“ ìš”ì•½

ì´ ë…¼ë¬¸ì€ íŒŒí‚¨ìŠ¨ë³‘ì˜ ìë™ ì§„ë‹¨ì„ ìœ„í•´ 2D ë¹„ì „ ê¸°ì´ˆ ëª¨ë¸(VFM)ì„ í™œìš©í•˜ëŠ” ë°©ë²•ì„ ì œì•ˆí•©ë‹ˆë‹¤. ê¸°ì¡´ì˜ 3D ì˜ë£Œ ëª¨ë¸ì„ í™œìš©í•˜ê¸° ì–´ë ¤ìš´ ë¬¸ì œë¥¼ í•´ê²°í•˜ê¸° ìœ„í•´, NM ë° QSM ì´ë¯¸ì§€ì—ì„œ ì—¬ëŸ¬ ê´€ì‹¬ ì˜ì—­(ROI)ì„ ì˜ë¼ë‚´ê³ , ê° ROIë¥¼ ë³„ë„ì˜ ë¶„ê¸°ë¡œ ì²˜ë¦¬í•˜ì—¬ í† í°ìœ¼ë¡œ ì••ì¶•í•œ í›„ ì´ë¥¼ í†µí•©í•˜ì—¬ í™˜ì í‘œí˜„ì„ ìƒì„±í•©ë‹ˆë‹¤. ê° ë¶„ê¸°ì—ì„œëŠ” 2D VFMì„ ì‚¬ìš©í•˜ì—¬ 3D ROI ë³¼ë¥¨ì˜ ì¶• ë°©í–¥ ìŠ¬ë¼ì´ìŠ¤ë¥¼ ì¸ì½”ë”©í•˜ê³ , ë³´ì¡° ë¶„í•  í—¤ë“œë¥¼ í†µí•´ íŠ¹ì • ë‡Œ í•µìœ¼ë¡œì˜ íŠ¹ì§• ì¶”ì¶œì„ ìœ ë„í•©ë‹ˆë‹¤. ë˜í•œ, ë‹¤ì¤‘ ROI ê°ë… ëŒ€ì¡° í•™ìŠµì„ ë„ì…í•˜ì—¬ ê°™ì€ í´ë˜ìŠ¤ì˜ í™˜ì í‘œí˜„ì„ ê°€ê¹Œì´í•˜ê³  ë‹¤ë¥¸ í´ë˜ìŠ¤ì˜ í‘œí˜„ì„ ë©€ë¦¬í•¨ìœ¼ë¡œì¨ ì§„ë‹¨ ì„±ëŠ¥ì„ í–¥ìƒì‹œí‚µë‹ˆë‹¤. ì´ ì ‘ê·¼ë²•ì€ MICCAI 2025 PDCADxFoundation ì±Œë¦°ì§€ì—ì„œ 86.0%ì˜ ì •í™•ë„ë¡œ 1ìœ„ë¥¼ ì°¨ì§€í–ˆìœ¼ë©°, ì´ëŠ” 300ê°œì˜ ë¼ë²¨ë§ëœ QSM ë° NM-MRI ìŠ¤ìº” ë°ì´í„°ì…‹ìœ¼ë¡œ í›ˆë ¨ëœ ê²°ê³¼ë¡œ, 2ìœ„ ë°©ë²•ë³´ë‹¤ 5.5% ë†’ì€ ì„±ëŠ¥ì„ ë³´ì˜€ìŠµë‹ˆë‹¤. ì´ ê²°ê³¼ëŠ” 2D VFMì´ 3D MR ì´ë¯¸ì§€ì˜ ì„ìƒ ë¶„ì„ì— ìœ ë§í•œ ê°€ëŠ¥ì„±ì„ ì§€ë‹˜ì„ ê°•ì¡°í•©ë‹ˆë‹¤.

## ğŸ¯ ì£¼ìš” í¬ì¸íŠ¸

- 1. íŒŒí‚¨ìŠ¨ë³‘ì˜ ìë™ ì§„ë‹¨ì„ ìœ„í•´ NM ë° QSM ì´ë¯¸ì§€ë¥¼ í™œìš©í•˜ì—¬ ë‹¤ì¤‘ ROIë¥¼ ì¶”ì¶œí•˜ê³ , ì´ë¥¼ í†µí•©í•˜ì—¬ í™˜ì í‘œí˜„ìœ¼ë¡œ ë¶„ë¥˜í•˜ëŠ” ë°©ë²•ì„ ì œì•ˆí•©ë‹ˆë‹¤.
- 2. 2D ë¹„ì „ ê¸°ì´ˆ ëª¨ë¸(VFMs)ì„ ì‚¬ìš©í•˜ì—¬ 3D ROI ë³¼ë¥¨ì˜ ì¶• ë°©í–¥ ìŠ¬ë¼ì´ìŠ¤ë¥¼ ì¸ì½”ë”©í•˜ê³ , ë³´ì¡° ë¶„í•  í—¤ë“œë¥¼ í†µí•´ íŠ¹ì • ë‡Œ í•µìœ¼ë¡œì˜ íŠ¹ì§• ì¶”ì¶œì„ ìœ ë„í•©ë‹ˆë‹¤.
- 3. ë‹¤ì¤‘ ROI ì§€ë„ ëŒ€ì¡° í•™ìŠµì„ ë„ì…í•˜ì—¬ ê°™ì€ í´ë˜ìŠ¤ì˜ í™˜ì í‘œí˜„ì„ ê°€ê¹Œì´ ëª¨ìœ¼ê³  ë‹¤ë¥¸ í´ë˜ìŠ¤ì˜ í™˜ì í‘œí˜„ì„ ë©€ë¦¬ ë–¨ì–´ëœ¨ë¦¼ìœ¼ë¡œì¨ ì§„ë‹¨ ì„±ëŠ¥ì„ í–¥ìƒì‹œí‚µë‹ˆë‹¤.
- 4. ì œì•ˆëœ ë°©ë²•ì€ MICCAI 2025 PDCADxFoundation ì±Œë¦°ì§€ì—ì„œ 86.0%ì˜ ì •í™•ë„ë¡œ 1ìœ„ë¥¼ ì°¨ì§€í–ˆìœ¼ë©°, 300ê°œì˜ ë¼ë²¨ë§ëœ QSM ë° NM-MRI ìŠ¤ìº” ë°ì´í„°ì…‹ì—ì„œ í›ˆë ¨ë˜ì—ˆìŠµë‹ˆë‹¤.
- 5. 2D VFMsê°€ 3D MR ì´ë¯¸ì§€ì˜ ì„ìƒ ë¶„ì„ì— ìˆì–´ ì ì¬ë ¥ì´ ìˆìŒì„ ê°•ì¡°í•©ë‹ˆë‹¤.


---

*Generated on 2025-09-24 00:01:55*